Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Vulvar Neoplasms 1Vulvar Diseases 1Vomiting 1Uterine Cervical Dysplasia 1Sarcoma, Alveolar Soft Part 1Papillomavirus Infections 1Nausea 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Inflammatory Breast Neoplasms 1Gynecologic Cancer 1Colonic Neoplasms 1Carcinoma in Situ 1Burkitt Lymphoma 1Breast Neoplasms, Male 1

Interventions

Dexamethasone 21Palonosetron 16Aprepitant 14Ondansetron 12Calcium Dobesilate 11Granisetron 7fosaprepitant 6dexamethasone acetate 5Doxorubicin 4netupitant, palosentron drug combination 3dexamethasone 21-phosphate 3Olanzapine 3Diphenhydramine 3Cyclophosphamide 3Cisplatin 3netupitant 2Vincristine 2Therapeutics 2Surveys and Questionnaires 2Sugars 2Radiotherapy 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2rolapitant 1phenazine 1ginger extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Vomiting × Prochlorperazine × Clear all
NCT00475085 2015-11-10

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

University of Rochester

Phase 3 Completed
1,021 enrolled 10 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡